Brandywine Global Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-121,400
Closed -$2.95M 672
2024
Q3
$2.95M Sell
121,400
-51,600
-30% -$996K 0.02% 485
2024
Q2
$2.9M Sell
173,000
-114,700
-40% -$1.84M 0.02% 505
2024
Q1
$3.72M Hold
287,700
0.03% 461
2023
Q4
$3.33M Buy
287,700
+30,500
+12% +$344K 0.03% 469
2023
Q3
$3.28M Buy
257,200
+44,900
+21% +$637K 0.03% 459
2023
Q2
$2.91M Buy
+212,300
New +$3.04M 0.02% 488

Other funds holding PAHC

Brandywine Global Investment Management's PAHC Position: Q4 2024 in Review

Brandywine Global Investment Management sold out of Phibro Animal Health (PAHC) in Q4 2024, closing a stake of 121,400 shares — an estimated $2.95M sold.

Brandywine Global Investment Management first reported a position in PAHC in Q2 2023 and held it in 6 quarters. The position peaked at $3.72M in Q1 2024. 172 funds tracked by Wall St. Rank hold PAHC as of Q4 2024.

  • Brandywine Global Investment Management reported no remaining Phibro Animal Health position as of Q4 2024 after selling out during the quarter.
  • Brandywine Global Investment Management sold 121,400 Phibro Animal Health shares in Q4 2024, an estimated $2.95M.
  • Brandywine Global Investment Management first reported a position in Phibro Animal Health in Q2 2023 and held it in 6 quarters.
  • Brandywine Global Investment Management's Phibro Animal Health position peaked at $3.72M in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2024.

Based on Brandywine Global Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.